LENZ Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 05, 2025 08:00 ET | Source: LENZ Therapeutics, Inc. VIZZTM (aceclidine…
Accademia Vallelunga: the world of Lamborghini fueled by adrenalin and lifestyle
An authentic experience as a professional driver on trackSant’Agata Bolognese, 28 October…
Xinhua Silk Road: 2025 Chishui River Forum to be held in Maotai Town, Guizhou on Oct. 28
BEIJING, Oct. 28, 2025 /PRNewswire/ -- The 2025 Chishui River Forum will…
Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships
- Successfully initiated enrollment in advanced Phase 2 ovarian cancer…
Instil Bio Announces U.S. F.D.A. Clearance of Investigational New Drug (IND) Application for AXN-2510, a PD-L1xVEGF Bispecific Antibody, for a Phase 1 Trial in Relapsed/Refractory Solid Tumors
July 02, 2025 06:00 ET | Source: Instil Bio US phase 1…
Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc.…